Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Fountoulakis KN, Yatham L, Grunze H, Vieta E, Young A, Blier P, Kasper S, Moeller HJ.

Int J Neuropsychopharmacol. 2016 Dec 22. pii: pyw100. doi: 10.1093/ijnp/pyw100. [Epub ahead of print] Review.

2.

Carbamazepine treatment of bipolar disorder: a retrospective evaluation of naturalistic long-term outcomes.

Chen CH, Lin SK.

BMC Psychiatry. 2012 May 23;12:47. doi: 10.1186/1471-244X-12-47.

3.

Anticonvulsant drugs in bipolar disorder.

Grunze H, Schlösser S, Amann B, Walden J.

Dialogues Clin Neurosci. 1999 Jun;1(1):24-40.

4.

Valproate in acute mania - a controlled study.

Prakash HM, Bharath S.

Indian J Psychiatry. 2000 Jan;42(1):94-7.

5.

Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis.

Tamayo JM, Zarate CA Jr, Vieta E, Vázquez G, Tohen M.

Int J Neuropsychopharmacol. 2010 Jul;13(6):813-32. doi: 10.1017/S1461145709991246. Epub 2010 Feb 4. Review.

6.

Bipolar disorder and mechanisms of action of mood stabilizers.

Rapoport SI, Basselin M, Kim HW, Rao JS.

Brain Res Rev. 2009 Oct;61(2):185-209. doi: 10.1016/j.brainresrev.2009.06.003. Epub 2009 Jun 23. Review.

7.

Acute and long-term treatment of mania.

Vieta E, Sanchez-Moreno J.

Dialogues Clin Neurosci. 2008;10(2):165-79. Review.

8.

Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.

Fountoulakis KN, Vieta E, Siamouli M, Valenti M, Magiria S, Oral T, Fresno D, Giannakopoulos P, Kaprinis GS.

Ann Gen Psychiatry. 2007 Oct 9;6:27.

9.

Anticonvulsant Use in the Treatment of Bipolar Disorder: A Primer for Primary Care Physicians.

Leo RJ, Narendran R.

Prim Care Companion J Clin Psychiatry. 1999 Jun;1(3):74-84.

10.

The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate.

Dilsaver SC, Swann AC, Shoaib AM, Bowers TC.

J Psychiatry Neurosci. 1993 Mar;18(2):61-6. Review.

11.

The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.

Simhandl C, Meszaros K.

J Psychiatry Neurosci. 1992 Mar;17(1):1-14. Review.

Supplemental Content

Support Center